Distribution of the Vang-Like Gene Cluster in Clostridium Difficile Clinical Isolates
Total Page:16
File Type:pdf, Size:1020Kb
547 NOTE / NOTE Distribution of the vanG-like gene cluster in Clostridium difficile clinical isolates Fariza Ammam, Jean-Christophe Marvaud, and Thierry Lambert Abstract: Treatment of Clostridium difficile infections generally requires cessation of their causative antibiotic and subse- quent administration of metronidazole or vancomycin. Intriguingly, the genome of C. difficile 630 contains a cryptic gene cluster homologous to the vanG-type operon of Enterococcus faecalis BM4518. We detected this cluster by PCR in 35 out of 41 clinical isolates, confirming its large prevalence in this species. The cluster was found to be located in a unique locus. Comparison of this locus with that of strains devoid of the vanG-like cluster indicated that acquisition of the gene cluster occurred in a perfect 19-bp inverted repeat, in the absence of a detectable mobile structure. Key words: vanG-like, Clostridium difficile, cryptic genes. Résumé : Le traitement des infections liées à Clostridium difficile requiert en général l’arrêt de l’antibiothérapie responsable de l’implantation du microorganisme et l’administration du métronidazole ou de la vancomycine. Le génome de la souche C. difficile 630 héberge un groupe de gènes cryptiques homologue à l’opéron vanG de Enterococcus faecalis BM4518. Nous avons détecté ce groupe de gènes désigné vanG-like par PCR chez 35 parmi 41 isolats cliniques. Ce résultat reflète la forte prévalence de ce groupe de gènes chez C. difficile. Par ailleurs, vanG-like a été retrouvé localisé dans un même locus. La comparaison de ce locus avec celui des souches dépourvues de vanG-like indique que l’acquisition de ce dernier s’opère au niveau d’une séquence inversée répétée de 19 pb en l’absence d’une structure d’élément mobile identifiable. Mots‐clés : vanG-like, Clostridium difficile, gènes cryptiques. [Traduit par la Rédaction] For personal use only. Clostridium difficile is the cause of 15%–20% of cases of are the most prevalent vancomycin resistance determinants in antibiotic-associated diarrhea and of most cases of pseudo- enterococci (Arthur and Courvalin 1993; Evers et al. 1996). membranous colitis. Metronidazole and vancomycin are the The VanG-type is characterized by a low-level resistance to major antibiotics for treatment of C. difficile infections vancomycin (minimum inhibitory concentration 16 µg/mL) (Kachrimanidou and Malisiovas 2011). In silico analysis of and susceptibility to teicoplanin (Depardieu et al. 2003). The the C. difficile 630 genome revealed the presence of a gene vanG-like cluster of C. difficile includes five open reading cluster homologous to the vanG operon, which confers van- frames for putative proteins that share identity with VanRG comycin resistance in Enterococcus faecalis BM4518 (82%); VanSD and VanSG (59% and 50%, respectively); (Depardieu et al. 2003; Sebaihia et al. 2006). Glycopeptide VanG (66%); VanXYG (58%); and VanTG (62%), correspond- resistance in enterococci is due to a double mechanism that ing, respectively, to the regulator, sensor, D-Ala-D-Ser ligase, combines synthesis of modified peptidoglycan precursors D-D, peptidase, and serine racemase encoded by the vanG ending in D-alanyl-D-lactate (VanA, VanB, VanD, and operon. Despite the presence of genes homologous to the Can. J. Microbiol. Downloaded from www.nrcresearchpress.com by Health Canada on 01/22/20 VanM) or D-alanyl-D-serine (VanC, VanE, VanG, VanL, and vanG operon, C. difficile remains susceptible to vancomycin. VanN) of low affinity for glycopeptide and elimination of This observation raises the question of the origin of these natural D-alanyl-D-alanine precursors (Boyd et al. 2008; genes and of their ability to generate vancomycin resistance. Courvalin 1990; Lebreton et al. 2011; Reynolds and Whole-genome microarray analysis of diverse C. difficile Courvalin 2005; Xu et al. 2010). This mechanism involves strains has shown large genome variability and the absence enzymatic activities encoded by genes organized in operons. of the vanG-like cluster in several strains (Sebaihia et al. Resistance to glycopeptide, first described in enterococci, has 2006). Thus we analyze here the distribution of this element now spread to other Gram-positive bacteria. VanA and VanB in C. difficile clinical isolates from various origins. Received 18 November 2011. Revision received 15 December 2011. Accepted 16 December 2011. Published at www.nrcresearchpress.com/cjm on 12 March 2012. F. Ammam, J.-C. Marvaud, and T. Lambert. EA 4043, USC INRA, Département de Microbiologie, Faculté de Pharmacie, Université Paris Sud, Châtenay-Malabry, France. Corresponding author: Jean-Christophe Marvaud (e-mail: [email protected]). Can. J. Microbiol. 58: 547–551 (2012) doi:10.1139/W2012-002 Published by NRC Research Press 548 Can. J. Microbiol. Vol. 58, 2012 Table 1. Characteristics of Clostridium difficile strains. Clinical vanG-like Strain TcdA TcdB PCR ribotypea Source country datab Year clusterc 630 A+B+ 012 Switzerland AAD 1982 + CD196 A+B+ 027 France PMC 1985 + 7241 A+B+ X France D 2000 + 89-638 A+B+ 014/020 France AC + 79-658 A+B+ ND France PMC + 3048 A+B+ X France D – 3751 A+B+ X France D 2003 + 1409 A+B+ 015 France U 2003 + 96-1827 A+B+ ND France U + FM 16 A+B+ X France PMC 1999 + FM 15 A–B+ 015 France PMC 1999 + 5445 A+B+ X France D 2000 + 94-416 A+B+ 031/053/057 France U + 4602 A+B+ 078/126 France U 2001 – 2348 A+B+ 014/020/077 France D + 4583 A–B+ 023 France D 2003 + 90-204 A+B+ ND France AC + 95-938 A+B+ ND France U + TL 1143 A–B+ 017 USA U – 4406 A+B+ 001 France D 2003 + 3457 A+B+ ND France D 2003 + 3290 A+B+ 015 France D + CD1 A+B+ ND Italia AAD 1999 + CD3 A+B+ X Italia AAD 1999 – CD20 A+B+ ND Italia AAD 1998 + C-253 A+B+ 012 Italia U + MI65 A+B+ ND Italia AAD 1992 + ATCC 43596 A+B+ 012 Belgium U + ATCC 43597 A–B– 010 Belgium U + ATCC 43598 A–B+ 017 Belgium AAD – For personal use only. ATCC 43599 A+B+ 001/115 Belgium U + ATCC 43600 A+B+ 014/020 Belgium U + ATCC 43601 A–B– ND Belgium U + ATCC 43602 A–B– 031/053/057 Belgium U + 4641 A+B+ ND France U + 56026 A–B– ND Belgium U + 95-1011 A+B+ ND France U + GAI 97482 A+B+ ND Japan AC 1998 + FM 12 A+B+ ND Canada PMC + FM 13 A+B+ 013 Canada PMC – FM 43 A+B+ ND Canada U + B1 A+B+ ND England PMC 1988 + aX, different than 001, 002, 003, 012, 014/020/077, 015, 017, 023, 027, 029, 046, 053, 056, 070, 075, 078/126, 081, 087, 095, 106, Can. J. Microbiol. Downloaded from www.nrcresearchpress.com by Health Canada on 01/22/20 117, 131; ND, not documented. Ribotypes in bold are from Eidhin et al. (2006). bAAD, antibiotic-associated diarrhea; PMC, pseudo-membranous colitis; D, diarrhea; AC, asymptomatic carriage; U, unknown. c+, present; –, absent. A total of 41 C. difficile strains were collected from various 6 strains devoid of the vanG-like cluster belonged to at least 4 geographical sources (France, Canada, Belgium, USA, Eng- different ribotypes. These data minimize a risk of redundancy. land, Switzerland, and Japan) and different clinical issues, in- Bacteria were grown overnight at 37 °C in an anaerobic cluding toxigenic (TcdA+ TcdB+ or TcdA– TcdB+) or atmosphere, on Brain Heart Infusion agar supplemented with nontoxigenic strains (Table 1). To avoid impacting sampling 5% defibrillated horse blood (BioMérieux, France). Genomic by strains’ clonality, French isolates, which represented 22 DNA was obtained using genomic DNA extraction kit (GFX out of 41 isolates of the study, were screened on the basis of Genomic Blood DNA Purification Kit, GE Healthcare) ac- a putative epidemiological link for PCR ribotyping analysis cording to the instructions of the supplier. Primers used for according to a procedure described elsewhere (Bidet et al. PCR mapping or sequencing are listed in Table 2. Briefly, 2000). Accordingly, 12 isolates analyzed were found to be dis- the presence of the vanG-like cluster in different strains was tributed in at least 7 PCR ribotypes (Table 1). In addition, the tested with primers vanTF and vanTR specific for the vanTG- Published by NRC Research Press Ammam et al. 549 Table 2. Oligonucleotide primers used in this study. Primer Primer sequence (5′—3′) Positiona vanRF CAAAGCCATTTAACCCTTTGGA +1882210, +1882231 vanRR TCTCCCCATACAGCTTCAAACA –1882458, –1882480 vanSF TGGATAAGGCAGAGCGTCTTG +1883198, +1883218 vanSR CGCTCAAGTTTTTCCTCTGGA –1883544, –1883564 vanYF TCGTACTGCAGAAGAACAACAAG +1885360, +1885382 vanYR TGCGGATATCCCACATAACG –1885646, –1885666 vanTF TCGAGCTAGGTTATTGCGAACA +1886721, +1886742 vanTR GCCATCAATTCACAATCTTCTGG –1887022, –1887042 vanGF GTTTCGCAGAACCGTGTCAA +1884228, +1884247 vanGR ACCAAATGATGAACCTGCAC –1884610, –1884629 N630 GATGGTTCATTAGTTGGAGCTATAC +1881359, +1881383 S630 CAAGTGGTAAGGCTGGTATAAAGC –1888465, –1888487 vanTF2 CTATTGGCTATGCCGATGGT +1887782, +1887801 vanR630 CTAGAGCTTCCTTACCTGTATAAAAC –1882001, –1882026 a+, sense primer; –, antisense primer. Nucleotide numbering is according to GenBank acc. No. AM180355.1. Fig. 1. Schematic representation of the vanG-like cluster from Clostridium difficile 630. vanTG-like positive strains (A) and vanTG-like negative strains (B) were further analyzed for PCR mapping with the primers indicated by arrowheads. The size of amplified regions is in- dicated in bp. For personal use only. like gene, which yielded a 324 bp amplicon. In the absence California) and Applied Biosystems ABI-PRISM-DNA ana- of a PCR product, primer pairs vanSF and vanSR, vanRF lyzer with N630 and S630 primers. Pairwise alignments of and vanRR, vanGF and vanGR, vanYF and vanYR were DNA sequences and identification of repeat motifs in DNA used to detect the vanSG-like, vanRG-like, vanG-like, and sequences were carried out using the program ClustalW2 vanXYG-like genes, respectively (Fig. 1B). In the vanTG-like (Larkin et al. 2007) and the program REPuter (Kurtz et al.